{"id":"7c2b9113-51be-4b09-b9fc-887b0e21438d","arxiv_id":"2506.16972","paper_version":1,"verdict":"CONDITIONAL","confidence":"MODERATE","novelty_score":6.0,"correctness_risk":"medium","formal_verification":"none","parameter_count":5,"one_line_summary":"Polarized neutron reflectometry on cell-free-expressed MscL in tethered lipid bilayers shows the fitted C-terminal protrusion drops from about 46 to 38 Å after adding pexiganan, consistent with gating toward the open state.","lead":"Neutron measurements on a flexible artificial membrane show that a bacterial pressure-relief channel, MscL, shortens its protruding tail by about 8 Å after contact with the antimicrobial peptide pexiganan, a change consistent with the channel beginning to open. This is the first direct structural experiment linking an antimicrobial peptide to a conformational change in this channel, a candidate antibiotic target.","discovery_kind":"new_method","skeptic_critique":{"model":"deepseek-v4-flash","headline":"The 46-to-38 Å protrusion change is assigned to MscL in a model that omits pexiganan; a peptide layer could mimic the same reflectivity change, so the central attribution is not yet secured.","rationale":"The reader's weakest_assumption identifies exactly the load-bearing issue: pexiganan is absent from the scattering model, so the fitted protrusion decrease is not unambiguously a protein conformational change. This is not an external-consensus disagreement; it is an internal identifiability problem in the reflectivity analysis. The paper's own text concedes the peptide is not modeled and cites an external thesis rather than a direct measurement of peptide partitioning in this system. Because the PNR data provide only scattering length density profiles, any unmodeled peptide at the membrane/protrusion interface will contribute to the same fitted layers; the 46-to-38 Å shift could therefore be, at least in part, a peptide contrast effect. The absence of a protein-free peptide control and the single-bilayer measurement leave this ambiguity unresolved. The SANS lyso-PC data and the internal consistency of the bilayer-coverage calculation provide supporting evidence that MscL is present and can undergo conformational changes, but they do not identify the specific PNR thickness change with MscL. The recommended concrete test, re-fitting with an explicit peptide layer, would settle whether the claim survives; without it, CONDITIONAL is the appropriate verdict. Since the reader already recommended CONDITIONAL for this same reason, no verdict adjustment is needed.","tokens_in":39510,"tokens_out":4107,"duration_ms":49121,"concrete_test":"Re-fit the 1.6 µM and 3.2 µM PXG PNR datasets with an extended model that includes a PXG layer at the bilayer/solvent interface, using the known pexiganan scattering length density and allowing peptide:lipid ratio to vary over a physically plausible range (e.g., 1:100 to 1:10), with the same Bayesian MCMC and model comparison (log-evidence) used in SI Section 2. If the MscL protrusion thickness posterior still centers near 38 Å and the model evidence favors the no-peptide model, the attribution is supported; if the protrusion thickness returns to ~46 Å or the peptide-layer model is favored, the conformational-change claim is not established.","verdict_should_be":"UNCHANGED","load_bearing_attack":"The central claim is that PNR shows a conformational change in the MscL C-terminal protrusion, with fitted thickness falling from 46±3 Å to 38±3 Å (1.6 µM) and 38±5 Å (3.2 µM) in Table II. However, Section II.G and SI Section 2 state explicitly: 'Pexiganan is not explicitly included in the model.' The justification is a low peptide:lipid ratio from a prior thesis measurement (ref 46), not an assay in the present tethered bilayer system. Pexiganan is an amphipathic cationic peptide known to insert at the lipid headgroup/tail interface; after the buffer rinse it will remain in the bilayer, and its neutron scattering length density will contribute to the very layers whose SLD and thickness are being fitted. In D2O/GMW/H2O contrasts, a thin peptide-rich layer at the outer headgroup or protrusion interface can change the apparent slab structure; because the model forces all SLD changes into the MscL volume fraction and protrusion thickness parameters, a peptide contribution would be absorbed as an apparent protein conformational change. No protein-free POPC:POPG tethered bilayer challenged with pexiganan is reported, and the PNR sequence was performed on a single bilayer. The posterior shift in Fig. 7 demonstrates only that the no-peptide model prefers a smaller protrusion thickness after peptide addition; it does not validate the model's assignment of that thickness to protein structure rather than to unmodeled peptide.","agreement_with_reader":"agree"},"referee_report":{"model":"deepseek-v4-flash","summary":"The manuscript reports a cell-free, detergent-free expression of the mechanosensitive channel MscL into POPC:POPG vesicles, SANS characterization of the vesicle-embedded protein (Rg = 26-29 Å), formation of PEG-tethered lipid bilayers on gold, and polarized neutron reflectivity (PNR) analysis of the bilayer before and after exposure to the antimicrobial peptide pexiganan. The fitted thickness of the MscL protrusion decreases from 46 ± 3 Å to 38 ± 3 Å at 1.6 μM pexiganan and to 38 ± 5 Å at 3.2 μM (Table II), with a shifted posterior distribution (Fig. 7). The authors interpret this as the first direct experimental evidence of an AMP-induced conformational change in the C-terminal protrusion of MscL, consistent with channel gating.","tokens_in":39922,"tokens_out":5994,"duration_ms":63452,"significance":"If the attribution holds, this is a valuable structural observation linking antimicrobial-peptide action to MscL gating, with potential implications for antibiotic mechanisms and drug design. The experimental platform is a genuine advance: cell-free expression avoids detergents, the polymeric tether provides a flexible membrane mimetic, and the PNR analysis uses three solvent contrasts and two spin contrasts with Bayesian posterior sampling. The authors provide the fitting code and data repository, which strengthens reproducibility. The two peptide concentrations give consistent thickness values, and the model selection for protrusion orientation is based on log-evidence. However, the central interpretation rests on an unvalidated assumption that pexiganan contributes negligibly to the reflectivity; the reported 'direct experimental evidence' is therefore not yet secured.","major_comments":[{"comment":"The central claim—that the 46-to-38 Å protrusion decrease reflects an MscL conformational change—relies on a model in which pexiganan is not explicitly included. As stated in Section II.G and SI Section 2: 'Pexiganan is not explicitly included in the model.' Pexiganan is an amphipathic cationic peptide known to insert at the lipid headgroup/tail interface (ref. 9), and after the buffer rinse it will remain in the bilayer. This peptide contributes to the scattering length density in the very layers (outer headgroup and protrusion region) whose thickness and SLD are being fitted. Because the model contains no peptide component, all post-peptide SLD changes are absorbed into the MscL protrusion thickness, the protein coverage, and the bilayer coverage parameters. A thin peptide-rich layer at the outer leaflet or at the base of the protrusion could plausibly mimic a reduced protrusion thickness. The justification for omitting the peptide is a prior thesis measurement (ref. 46) rather than a measurement in the present tethered-bilayer system, and no protein-free POPC:POPG tethered bilayer challenged with pexiganan is reported. To secure the attribution, the authors should either (i) add an explicit pexiganan layer to the model with the peptide:lipid ratio constrained by an independent assay, or (ii) measure a protein-free control bilayer under the same pexiganan challenge. Without one of these, the claim of 'first direct experimental evidence' is overstated.","section":"Section II.G and SI Section 2"}],"minor_comments":[{"comment":"The argument that the increase in bilayer coverage from 0.66 to 0.73 is 'a signature of channel opening' is a consistency check rather than an independent prediction: the predicted value of 0.72 is derived from the fitted pre-peptide protein coverage (13.7%) and an assumed open-channel radius of 35 Å, while the post-peptide protein coverage is itself a fitted parameter that decreases to 9-11%. This supporting evidence should be rephrased as model-dependent consistency, not as confirmation.","section":"SI Section 2B and Table II"},{"comment":"The PNR experiment was performed on a single bilayer preparation. The agreement between the 1.6 and 3.2 μM pexiganan concentrations is encouraging, but an independent bilayer replicate would strengthen the generality of the reported 8 Å protrusion decrease.","section":"Section III.D"},{"comment":"The protein scattering length density depends on assumed H/D exchange fractions (0.7 for the transmembrane region and 0.9 for the cytoplasmic region). The authors do not report a sensitivity analysis of these values; a brief test over a plausible range would clarify how robust the fitted protrusion thickness and its peptide-induced shift are to this assumption.","section":"SI Section 2 (Python code, sum_mscl)"},{"comment":"The SANS experiments with pexiganan show a 62.5% decrease in scattered intensity and creaming of lipid/protein, indicating vesicle destabilization. The authors should discuss whether analogous peptide-induced effects on the tethered bilayer could influence the fitted bilayer coverage or roughness parameters in the PNR analysis.","section":"SI Section 5B"},{"comment":"A few typographical errors should be corrected, including 'deterimental' in the Introduction and 'Bicinchronic acid' in SI Section 4 (should be 'bicinchoninic acid').","section":"Throughout"}],"recommendation":"major_revision","confidential_remarks":"This is a solid experimental study with a genuinely novel platform and careful error analysis. The main concern is the omission of pexiganan from the PNR model, which bears directly on the central claim. I would encourage the editor to require either an explicit peptide-layer model with a measured peptide:lipid ratio or a protein-free bilayer control before accepting the 'direct experimental evidence' claim. The paper's strength in data availability and transparency is commendable."},"author_rebuttal":null,"desk_editor":{"model":"deepseek-v4-flash","letter":"The short version: this paper has a real, new measurement platform and a plausible central claim that pexiganan makes the MscL C-terminal protrusion shrink from 46 to 38 Å, but the attribution of that shrink to protein motion rather than to unmodeled peptide contrast is not yet fully secured. It deserves a serious referee, and the referee should push for a protein-free control and a model that includes a peptide layer.\n\nWhat's genuinely new: the detergent-free, tethered bilayer platform using cell-free-expressed MscL, with PNR and SANS characterization, plus the observation of a protrusion thickness change. That's a methodological step forward. They also provide code and data (Zenodo/GitHub), which is good practice. The SANS Rg of ~26–29 Å matches the crystal structure, supporting that they have individual channels, not clusters. The posterior distributions in Fig. 7 show a clear shift in protrusion thickness, and the two peptide concentrations agree at 38 Å.\n\nThe soft spots are the ones you'd expect. Pexiganan is not in the reflectivity model; the paper says a low peptide-to-lipid ratio from a prior thesis justifies omitting it, but that's not a measurement in this system. The stress-test note is on point: a thin peptide-rich layer at the headgroup/tail interface could absorb into the fitted protrusion thickness. Without a protein-free bilayer plus pexiganan control, the central attribution remains model-dependent. Also, the PNR sequence is a single bilayer, so no replicate. The SANS pexiganan experiment suffered from creaming, which the authors acknowledge; the Rg change there is suggestive but not clean. The bilayer coverage increase is explained by a geometric argument in the SI, but that argument uses fitted pre-peptide values, so it's a consistency check, not independent evidence.\n\nI don't think these flaws are fatal. The paper is careful, the interpretation is hedged appropriately, and the authors explicitly call for patch-clamp follow-up. The central claim might well be right, but it's not yet nailed down.\n\nOverall: if you work on membrane protein structure or peptide-membrane interactions, this is worth reading and worth citing. I'd accept it for peer review with the expectation of major revisions — add a protein-free peptide control, put a peptide slab in the model, and ideally repeat the PNR on a second bilayer. That would turn a plausible result into a convincing one.","headline":"Promising new tethered-bilayer PNR platform shows a real 46-to-38 Å protrusion change in MscL on pexiganan, but the peptide is left out of the model, so the attribution to a protein conformational change needs one more control.","tokens_in":40433,"tokens_out":2330,"would_cite":true,"duration_ms":24082,"reading_group":"yes","serious_thinker":"yes","would_accept_peer_review":true},"rs_alignment":null,"lean_confirmation":null,"pith_extraction":{"msc":[],"pacs":[],"model":"deepseek-v4-flash","headline":"Pexiganan shortens the C-terminal protrusion of the mechanosensitive channel MscL by about 8 Å, the first direct evidence that an antimicrobial peptide triggers a gating-like conformational change.","keywords":["MscL","mechanosensitive ion channel","antimicrobial peptide","pexiganan","neutron reflectometry","tethered lipid bilayer","cell-free protein expression","small-angle neutron scattering"],"falsifier":"A protein-free POPC:POPG tethered bilayer measured by polarized neutron reflectivity before and after 1.6 µM pexiganan would settle the point: if the apparent protrusion-layer thickness or scattering length density changes by roughly the same 8 Å, the MscL conformational assignment is not supported. A complementary check is patch-clamp recording of MscL proteoliposomes at 1.6 µM pexiganan, which should show channel opening if the structural change is gating.","tokens_in":39309,"feed_emoji":"🧬","tokens_out":8043,"duration_ms":74371,"temperature":0.7,"pith_summary":"This paper seeks to establish that the antimicrobial peptide pexiganan does more than perturb the lipid bilayer: it triggers a conformational change in the mechanosensitive ion channel MscL, the bacterial pressure-relief valve. Using polarized neutron reflectivity on a polymer-tethered lipid bilayer containing cell-free expressed MscL, the authors measure the solvent-facing C-terminal protrusion of the channel shrinking from 46 ± 3 Å to 38 ± 3 Å after exposure to 1.6 µM pexiganan and remaining near 38 Å at 3.2 µM. They argue that this shortening matches the retraction of the C-terminus into the transmembrane domain predicted for channel opening, and they support the assignment with small-angle neutron scattering on MscL vesicles showing a comparable radius-of-gyration increase. A sympathetic reader would care because it offers a structural mechanism by which antimicrobial peptides could kill bacteria by gating open an ion channel, at concentrations below those needed for wholesale membrane disruption.","feed_headline":"Pexiganan shortens MscL's gating protrusion by 8 Å","feed_subtitle":"This is the first direct evidence that an antimicrobial peptide triggers MscL's gating conformation.","key_machinery":"The load-bearing measurement is polarized neutron reflectivity (PNR) from a polymer-tethered bilayer, modelled as a stack of slabs from the silicon substrate out to solution: oxide, permalloy, gold, PDP anchor, PEG brush, inner and outer lipid leaflets, and a final slab representing the MscL protrusion. The lipid leaflets are parametrized by area per molecule and water molecules per lipid head, the transmembrane protein enters as a volume fraction, and the protrusion slab has its own fitted thickness; Bayesian posterior sampling is used to estimate parameter uncertainties and to show that the protrusion-thickness posterior shifts after pexiganan addition. Supporting characterization comes from small-angle neutron scattering of MscL-containing vesicles, where a two-level Guinier-Porod fit yields a protein radius of gyration of 26–29 Å, matching the crystal structure of individual MscL channels and indicating that the channels are incorporated as unclustered monomers rather than large aggregates.","core_discovery":"The central claim is that pexiganan induces a conformational change in MscL that appears as a decrease in the fitted thickness of the channel's C-terminus-containing protrusion in a tethered lipid bilayer: from 46 ± 3 Å in the pristine bilayer to 38 ± 3 Å at 1.6 µM and 38 ± 5 Å at 3.2 µM pexiganan, with the Bayesian posterior for this parameter shifting to lower values. The accompanying changes, protein coverage falling from 14% to 9–11% and bilayer coverage rising from 0.66 to 0.71–0.73, are shown by the authors to be the expected signature of open channels occluding a larger area than closed channels. The authors present this as the first direct experimental evidence of an antimicrobial peptide triggering a structural change in the C-terminus of MscL, consistent with a gating motion previously predicted by molecular dynamics and inferred from EPR and FRET measurements.","pith_inferences":["Beyond the paper: if pexiganan gates MscL open at sub-MIC concentrations, combination therapies pairing antimicrobial peptides with antibiotics that enter through the MscL pore, such as streptomycin-like aminoglycosides, should show synergistic killing; this is testable in bacterial viability assays.","Beyond the paper: the protrusion thickness being 38 Å at both 1.6 and 3.2 µM pexiganan suggests a two-state transition rather than a graded response, and patch-clamp recordings at intermediate concentrations would reveal whether the structural change is all-or-none.","Beyond the paper: because pexiganan is absent from the reflectivity model, a protein-free bilayer control exposed to pexiganan would determine how much of the apparent protrusion change is peptide contrast; without that control, the quantitative 8 Å number is tied to the model's assumption.","Beyond the paper: using deuterated pexiganan would change the peptide's scattering length density and allow the peptide's own location to be fitted rather than omitted, providing a direct test of where the peptide acts."],"forward_implications":["If the protrusion shortening is genuine, PNR on tethered bilayers provides a direct structural readout of MscL gating that does not require detergents or protein clustering.","The correlated rise in bilayer coverage and fall in protein coverage can serve as a secondary fingerprint of channel opening in future screens of antimicrobial peptides.","The result places a structural constraint on models of MscL gating: the C-terminus retracts by roughly 8 Å toward the transmembrane domain rather than moving outward.","Because the change saturates between 1.6 and 3.2 µM pexiganan, the effect occurs at the lower end of reported minimum inhibitory concentrations, suggesting channel gating precedes membrane disruption.","The same tethered-bilayer platform can be applied to other amphipathic drugs and MscL mutants to test whether gating-like conformational changes are a general antimicrobial-peptide mechanism."],"supporting_citations":[{"why":"Supplies the crystal structure of the MscL homolog and the expected C-terminal protrusion length used to assign the fitted 46 Å layer.","marker":"[20]"},{"why":"The deposited 2OAR structure used to estimate the protein radius of gyration, about 28 Å, and the protrusion dimensions.","marker":"[21]"},{"why":"Establishes that amphipathic molecules activate MscL, the prior observation this study extends to a peptide-induced structural change.","marker":"[26]"},{"why":"Provides the molecular-dynamics and EPR/FRET-based prediction that the C-terminus retracts into the transmembrane domain on gating, against which the measured 46 to 38 Å change is compared.","marker":"[34]"},{"why":"The prior study that justifies omitting pexiganan from the reflectivity model by reporting a low peptide-to-lipid ratio; the central assumption of the analysis rests on this.","marker":"[46]"},{"why":"Describes C-terminal domain structural dynamics, supporting the assignment of the protrusion change to C-terminus movement.","marker":"[62]"},{"why":"Proposes the N-terminus and transmembrane gating mechanism and the outward bending of the upper C-terminal helices that the observed density redistribution is compared with.","marker":"[63]"}],"fun_headline_variants":["First direct evidence: pexiganan shrinks MscL protrusion by 8 Å","MscL gating protrusion shortens 8 Å with pexiganan","Antimicrobial peptide triggers MscL's gating motion","Neutron reflectometry shows pexiganan remodels MscL","Pexiganan compresses MscL's gating protrusion"],"cache_read_input_tokens":3200,"weakest_assumption_plain":"The load-bearing assumption is that the fitted protrusion thickness decrease is caused by protein movement, not by pexiganan's own scattering contribution, since pexiganan is not included in the reflectivity model and the paper reports no protein-free bilayer-plus-pexiganan control.","fun_headline_variants_meta":{"raw":{"variants":["First direct evidence: pexiganan shrinks MscL protrusion by 8 Å","MscL gating protrusion shortens 8 Å with pexiganan","Antimicrobial peptide triggers MscL's gating motion","Neutron reflectometry shows pexiganan remodels MscL","Pexiganan compresses MscL's gating protrusion"]},"model":"deepseek-v4-flash","effort":"low","cost_usd":0.000757,"raw_usage":{"total_tokens":3444,"prompt_tokens":1106,"completion_tokens":2338,"prompt_tokens_details":{"cached_tokens":384},"prompt_cache_hit_tokens":384,"prompt_cache_miss_tokens":722,"completion_tokens_details":{"reasoning_tokens":2236}},"tokens_in":722,"tokens_out":2338,"duration_ms":17419,"temperature":1.0,"reasoning_tokens":2236,"cache_read_input_tokens":384,"cache_creation_input_tokens":0},"cache_creation_input_tokens":0},"created_at":"2026-08-15T19:15:59.460998+00:00","model_set":{"reader":"deepseek-v4-flash"},"falsifier":"A protein-free POPC:POPG tethered bilayer measured by polarized neutron reflectivity before and after 1.6 µM pexiganan would settle the point: if the apparent protrusion-layer thickness or scattering length density changes by roughly the same 8 Å, the MscL conformational assignment is not supported. A complementary check is patch-clamp recording of MscL proteoliposomes at 1.6 µM pexiganan, which should show channel opening if the structural change is gating.","supporting_citations":[{"cited_title":"Pabst, S","cited_arxiv_id":null,"evidence_quote":"Supplies the crystal structure of the MscL homolog and the expected C-terminal protrusion length used to assign the fitted 46 Å layer."},{"cited_title":"McKinley, Neutron reflectivity studies of bacterial membranes , peptides and proteins, Ph.D","cited_arxiv_id":null,"evidence_quote":"The deposited 2OAR structure used to estimate the protein radius of gyration, about 28 Å, and the protrusion dimensions."},{"cited_title":"Hammouda, A new guinier–porod model, Journal of Applied Crystallograph y 43 (4) (2010) 716–719","cited_arxiv_id":null,"evidence_quote":"Establishes that amphipathic molecules activate MscL, the prior observation this study extends to a peptide-induced structural change."},{"cited_title":null,"cited_arxiv_id":null,"evidence_quote":"Provides the molecular-dynamics and EPR/FRET-based prediction that the C-terminus retracts into the transmembrane domain on gating, against which the measured 46 to 38 Å change is compared."}],"review_version":1}